Table 5.
Population/Area | Class combined | ||
---|---|---|---|
Coveragea | Average_hitb | pc90c | |
Central Africa | 95.44% | 50.89 | 29.93 |
Central America | 92.54% | 42.49 | 26.86 |
East Africa | 96.18% | 57.81 | 32.85 |
East Asia | 89.15% | 43.81 | 23.02 |
Europe | 98.07% | 73.1 | 48.88 |
North Africa | 77.17% | 31.37 | 10.95 |
North America | 95.26% | 83.85 | 52.84 |
Northeast Asia | 95.88% | 55.83 | 31.84 |
Oceania | 97.62% | 70.37 | 43.99 |
South Africa | 18.36% | 4.83 | 3.06 |
South America | 94.9% | 79.69 | 45.58 |
South Asia | 98.71% | 57.87 | 35.16 |
Southeast Asia | 81.05% | 33.03 | 13.19 |
Southwest Asia | 79.38% | 32.6 | 12.12 |
West Africa | 97.95% | 74.52 | 51.06 |
West Indies | 89.23% | 44.6 | 23.21 |
World | 96.81% | 68.99 | 39.46 |
Average | 87.86 | 53.27 | 30.82 |
Standard deviation | 18.6 | 20.31 | 14.7 |
aProjected population coverage.
bAverage number of epitope hits / HLA combinations recognized by the population.
cMinimum number of epitope hits / HLA combinations recognized by 90% of the population.